Boston Scientific Corp (BSX)
Gross profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 11,224,000 | 10,707,000 | 10,225,000 | 10,169,000 | 9,871,000 | 9,511,000 | 9,276,000 | 8,969,000 | 8,679,000 | 8,606,000 | 8,444,000 | 8,342,000 | 8,129,000 | 7,678,000 | 7,438,000 | 6,522,000 | 6,401,000 | 6,744,000 | 6,881,000 | 7,533,000 |
Revenue (ttm) | US$ in thousands | 16,746,000 | 15,910,000 | 15,228,000 | 14,707,000 | 14,240,000 | 13,757,000 | 13,400,000 | 13,045,000 | 12,682,000 | 12,567,000 | 12,329,000 | 12,162,000 | 11,888,000 | 11,469,000 | 11,196,000 | 10,122,000 | 9,913,000 | 10,110,000 | 10,158,000 | 10,786,000 |
Gross profit margin | 67.02% | 67.30% | 67.15% | 69.14% | 69.32% | 69.14% | 69.22% | 68.75% | 68.44% | 68.48% | 68.49% | 68.59% | 68.38% | 66.95% | 66.43% | 64.43% | 64.57% | 66.71% | 67.74% | 69.84% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $11,224,000K ÷ $16,746,000K
= 67.02%
The gross profit margin of Boston Scientific Corp has shown some fluctuations over the past few years. It was relatively high at around 69% in the first half of 2020 but then decreased to around 64-66% by the end of the year. However, there was a positive trend in the following years, with the gross profit margin gradually increasing to around 69% by the beginning of 2024.
Overall, the company has seen improvement in its gross profit margin over the years, indicating efficient cost management and potentially higher pricing power. It is essential to continue monitoring this ratio to ensure sustained profitability and competitiveness in the market.
Peer comparison
Dec 31, 2024